Renjith Vijayakumar Selvarani: New Nanoparticle Approach Clears Brain Plaque and Restores Memory
Renjith Vijayakumar Selvarani, Founder, Chairman, Chief Scientific and Technology Officer at OLUSIUM, shared a post on LinkedIn about a recent article by et al, published in
“Scientists reversed Alzheimer’s symptoms with nanoparticles that cleared brain plaque and restored memory!
The new treatment cleared toxic proteins in 1 hour and reversed 6 months of cognitive decline.
In a groundbreaking development, Spanish and Chinese researchers have successfully used nanoparticles to clear Alzheimer’s-related brain plaque in mice, offering a promising new strategy in treating the disease.
The study, published in Signal Transduction and Targeted Therapy, demonstrated that just three injections of specially engineered nanoparticles reduced amyloid beta buildup in the brain by up to 60% within an hour. Even more remarkably, mice that had exhibited severe cognitive impairment began behaving normally within six months — a dramatic reversal attributed to restored function of the brain’s blood-brain barrier (BBB), a crucial defense system that becomes compromised in Alzheimer’s patients.
Rather than solely targeting plaque removal, the nanoparticles act as a ‘supramolecular drug’ to revive the BBB’s natural waste-clearing mechanisms, particularly a key protein known as LRP1. This approach tackles one of Alzheimer’s earliest warning signs: vascular damage that precedes memory loss in over 90% of patients.
By repairing the barrier’s function, the treatment improves blood flow, reduces inflammation, and allows the brain to recover its self-regulating processes. Though still in the animal-testing phase, the results open a novel research frontier that may transform how scientists detect and treat neurodegenerative diseases not just by cleaning up damage, but by restoring the body’s natural defenses.”
Title: Rapid amyloid-β clearance and cognitive recovery through multivalent modulation of blood–brain barrier transport
Authors: Junyang Chen, Pan Xiang, Aroa Duro-Castaño, Huawei Cai, Bin Guo, Xiqin Liu, Yifan Yu, Su Lui, Kui Luo, Bowen Ke, Lorena Ruiz-Pérez, Qiyong Gong, Xiaohe Tian, Giuseppe Battaglia
Read the Full Article on Signal Transduction and Targeted Therapy
Stay updated on all scientific advances with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers